Integral Diagnostics Ltd Capital Reinvestment Ratio
Integral Diagnostics Ltd capital reinvestment ratio. Integral Diagnostics Ltd (IDX) has a Capital Reinvestment Ratio of 0.64x as of June 2025, meaning it reinvests 1% of its operating cash flow (AU$51.60 Million) in capital expenditures (AU$32.90 Million). See IDX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Integral Diagnostics Ltd (2014–2025)
Capital reinvestment ratio of Integral Diagnostics Ltd from 2014 to 2025. This chart tracks Integral Diagnostics Ltd's Capital Reinvestment Ratio across 12 annual periods. See IDX FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Integral Diagnostics Ltd Capital Reinvestment Ratio by Year (2014–2025)
Integral Diagnostics Ltd capital reinvestment ratio by year from 2014 to 2025. For the full cash flow conversion analysis, see Integral Diagnostics Ltd operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.81x | AU$73.77 Million | AU$59.76 Million | ▲ +124.4% |
| 2024 | 0.36x | AU$66.16 Million | AU$23.88 Million | ▼ -41.4% |
| 2023 | 0.62x | AU$71.42 Million | AU$43.99 Million | ▼ -17.7% |
| 2022 | 0.75x | AU$37.10 Million | AU$27.77 Million | ▲ +156.9% |
| 2021 | 0.29x | AU$69.57 Million | AU$20.27 Million | ▼ -38.9% |
| 2020 | 0.48x | AU$54.25 Million | AU$25.88 Million | ▼ -13.3% |
| 2019 | 0.55x | AU$33.92 Million | AU$18.67 Million | ▲ +26.0% |
| 2018 | 0.44x | AU$26.52 Million | AU$11.58 Million | ▼ -14.8% |
| 2017 | 0.51x | AU$22.73 Million | AU$11.65 Million | ▼ -28.4% |
| 2016 | 0.72x | AU$24.05 Million | AU$17.22 Million | ▲ +527.0% |
| 2015 | 0.11x | AU$17.11 Million | AU$1.95 Million | ▼ -78.4% |
| 2014 | 0.53x | AU$3.70 Million | AU$1.95 Million | — |